Several management options are available when prostate cancer is diagnosed at an early stage. However, the optimal treatment for localized prostate cancer is unknown, and reports in the literature are controversial regarding the best treatment modality for this early presentation.
Methods
The authors review improvements in surgical technique that have decreased complications, and they address long-term outcomes of surgery related to cancer control.
Results
Improvements in surgical techniques allow for decreased intraoperative complications. The incidence of long-term complications such as incontinence and impotency is also reduced. The 5- and 10-year progression-free survival with radical prostatectomy has improved.
Conclusions
Surgery today is safer with improvements in techniques. The long-term outcomes with surgery are excellent and, in several series, better than outcomes achieved with other treatment modalities.
References
1.
Pow-SangJ.M., MarshburnJ.. Clinical practice guidelines for prostate cancer.Cancer Control.1996; 3: 526–530.
2.
ReinerW.G., WalshP.C.. An anatomical approach to the surgical management of the dorsal vein and Santorini's plexus during radical retropubic surgery.J Urol.1979; 121: 198–200.
3.
WalshP.C., DonkerP.J.. Impotence following radical prostatectomy: insight into etiology and prevention.J Urol.1982; 128: 492–497.
4.
MyersR.P., GoellnerJ.R., CahillD.R.. Prostate shape, external striated urethral sphincter and radical prostatectomy: the apical dissection.J Urol.1987; 138: 543–550.
5.
KleinE.A.. Modified apical dissection for early continence after radical prostatectomy.Prostate.1993; 22: 217–223.
GomezC.A., SolowayM.S., CivantosF.. Bladder neck preservation and its impact on positive surgical margins during radical prostatectomy.Urology.1993; 42: 689–693; discussion 693-694.
8.
HollabaughRSJr, DmochowskiR.R., KneibT.G.. Preservation of putative continence nerves during radical retropubic prostatectomy leads to more rapid return of urinary continence.Urology.1998; 51: 960–967.
9.
JohnH., HauriD.. Seminal vesicle-sparing radical prostatectomy: a novel concept to restore early urinary continence.Urology.2000; 55: 820–824.
10.
KlotzL., HeatonJ., JewettM.. A randomized phase 3 study of intraoperative cavernous nerve stimulation with penile tumescence monitoring to improve nerve sparing during radical prostatectomy.J Urol.2000; 164: 1573–1578.
11.
KimH.L., StoffelD.S., MhoonD.A.. A positive caver map response poorly predicts recovery of potency after radical prostatectomy.Urology.2000; 56: 561–564.
12.
HolzbeierleinJ., PetersonM., SmithJ.A.. Variability of results of cavernous nerve stimulation during radical prostatectomy.J Urol.2001; 165: 108–110.
FrazierH.A., RobertsonJ.E., PaulsonD.F.. Radical prostatectomy: the pros and cons of the perineal versus retropubic approach.J Urol.1992; 147(3 Pt 2): 888–890.
17.
ScolieriM.J., ResnickM.I.. The technique of radical perineal prostatectomy.Urol Clin North Am.2001; 28: 521–533.
KochM.O., SmithJAJr. Blood loss during radical retropubic prostatectomy: is preoperative autologous blood donation indicated?J Urol.1996; 156: 1077–1079; discussion 1079-1080.
21.
LittleJSJr, BihrleR., FosterR.S.. Early urethral catheter removal following radical prostatectomy: a pilot study.Urology.1995; 46: 429–431.
22.
KochM.O., SmithJAJr, HodgeE.M.. Prospective development of a cost-efficient program for radical retropubic prostatectomy.Urology.1994; 44: 311–318.
23.
CatalonaW.J., SmithD.S.. Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: intermediate-term results.J Urol.1998; 160(6 Pt 2): 2428–2434.
24.
PoundC.R., PartinA.W., EpsteinJ.I.. Prostate-specific antigen after anatomic radical retropubic prostatectomy: patterns of recurrence and cancer control.Urol Clin North Am.1997; 24: 395–406.
25.
ZinckeH., OesterlingJ.E., BluteM.L.. Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer.J Urol.1994; 152(5 Pt 2): 1850–1857.
26.
D'AmicoA.V., WhittingtonR., MalkowiczS.B.. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.JAMA.1998; 280: 969–974.
27.
PolascikT.J., PoundC.R., DeWeeseT.L.. Comparison of radical prostatectomy and iodine 125 interstitial radiotherapy for the treatment of clinically localized prostate cancer: a 7-year biochemical (PSA) progression analysis.Urology.1998; 51: 884–889; discussion 889-890.
28.
RamosC.G., CarvalhalG.F., SmithD.S.. Retrospective comparison of radical retropubic prostatectomy and 125iodine brachytherapy for localized prostate cancer.J Urol.1999; 161: 1212–1215.
29.
LitwinM.S., PastaD.J., YuJ.. Urinary function and bother after radical prostatectomy or radiation for prostate cancer: a longitudinal, multivariate quality of life analysis from the Cancer of the Prostate Strategic Urologic Research Endeavor.J Urol.2000; 164: 1973–1977.
30.
WeiJ.T., DunnR.L., MarcovichR.. Prospective assessment of patient reported urinary continence after radical prostatectomy.J Urol.2000; 164(3 Pt 1): 744–748.
31.
StanfordJ.L., FengZ., HamiltonA.S.. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study.JAMA.2000; 283: 354–360.
32.
WalshP.C., MarschkeP., RickerD.. Patient-reported urinary continence and sexual function after anatomic radical prostatectomy.Urology.2000; 55: 58–61.
33.
ChabarekN., MoraL., MartinezC.. Age as prognostic risk factor for post-operative complications after radical retropubic prostatectomy.Urol Pan.1999; 11: 17–19.
34.
RaboyA., AlbertP., FerzliG.. Early experience with extraperitoneal endoscopic radical retropubic prostatectomy.Surg Endosc.1998; 12: 1264–1267.
